Back to LYEL

GSK plc → LYEL

GSK plc LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
4
Latest value
$14.8M
Q3 2026
Peak value
$46.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$46.6M
Q1 2026$30.3M
Q2 2026$21.3M
Q3 2026$14.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$14.8M1.51M——
Q2 2026$21.3M1.51M——
Q1 2026$30.3M1.51M——
Q4 2025$46.6M1.51M——

Other funds holding LYEL

Other GSK plc positions

WVE

WAVE LIFE SCIENCES LTD

$310.2M
CRSP

CRISPR THERAPEUTICS AG

$175.7M
CRSP

CRISPR THERAPEUTICS AG

$168.9M
CRSP

CRISPR THERAPEUTICS AG

$153.2M
CRSP

CRISPR THERAPEUTICS AG

$144.3M
WVE

WAVE LIFE SCIENCES LTD

$132.3M
WVE

WAVE LIFE SCIENCES LTD

$106M
VIR

VIR BIOTECHNOLOGY INC

$95.6M